52696f401de72931241380fca959ced5.3wZrxpMC6TlyjpSlmyD1vEvI_ydYD1l6SyuCSEZTIEk.8kVSksIx3lQXzaH6xFXEz3-lqHIwXAkzFEPJDxECbw2nMViu11HEdyLHpA
04/11 Rothschild & Co Redburn Adjusts Price Target on IDEXX Laboratories to $700 From $665 MT
03/11 IDEXX Laboratories Delivered Strong Results Despite Lackluster Vet Visit Backdrop, UBS Says MT
03/11 IDEXX Laboratories' Q3 Results Reflect Ability to Sustain Robust Pricing Despite Lower Vet Visits, UBS Says MT
03/11 UBS Adjusts Price Target on IDEXX Laboratories to $700 From $627, Maintains Neutral Rating MT
03/11 Goldman Sachs Adjusts Price Target on IDEXX Laboratories to $800 From $740 MT
03/11 Top Midday Gainers MT
02/11 IDEXX Laboratories, Inc. Revises Earnings Guidance for the Full Year of 2026 CI
02/11 IDEXX raises forecast, betting diagnostics can offset weak vet visits RE
02/11 IDEXX Laboratories, Inc., Q3 2026 Earnings Call, Nov 02, 2026
02/11 IDEXX Laboratories, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2026 CI
02/11 IDEXX Laboratories' Q3 Comparable Earnings, Revenue Increase; 2026 Outlook Raised MT
02/11 Earnings Flash (IDXX) IDEXX Laboratories Posts Q3 Comparable EPS $3.96, vs. FactSet Est of $3.73 MT
02/11 Earnings Flash (IDXX) IDEXX Laboratories, Inc. Reports Q3 Revenue $1.21B, vs. FactSet Est of $1.19B MT
02/11 IDEXX Laboratories : Earnings snapshot Q3 2026 PU
02/11 IDEXX Laboratories Announces Third Quarter Results BU
27/10 UBS Adjusts IDEXX Laboratories Price Target to $627 From $670, Maintains Neutral Rating MT
20/10 Jefferies Adjusts Price Target on IDEXX Laboratories to $705 From $795 MT
16/10 JPMorgan Adjusts Price Target on IDEXX Laboratories to $750 From $775 MT
12/10 KeyBanc Initiates IDEXX Laboratories at Sector Weight MT
01/10 IDEXX Laboratories to Release 2026 Third Quarter Financial Results BU
01/10 IDEXX Laboratories Acquires Veterinary AI Platform CoVetAI MT
17/09 IDEXX Laboratories Adds Taeniid Tapeworm Detection to Parasite Testing Platform MT
17/09 IDEXX Laboratories Expands Faecal DX Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection CI
17/09 IDEXX Expands Faecal Dx Antigen Testing Platform in the United Kingdom with Taeniid Tapeworm Detection BU
16/09 IDEXX Laboratories, Inc. acquired CoVetAI Inc. CI

Become a member to access more news

New member
No results match your criteria
  1. Stock Market
  2. Stocks
  3. IDXX Stock
  4. News IDEXX Laboratories, Inc.